![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
ヨーロッパの研究所が開発した2028年までの検査市場予測 – 新型コロナウイルス感染症の影響と地域分析(臨床生化学、救命救急、血液学、微生物学、分子診断、免疫学、その他の検査タイプ)および用途(学術機関、臨床研究機関、病院)ごと検査機関、専門診断センター、その他)
市場紹介
臨床開発検査 (LDT) は、体外診断検査の一種であり、国内で設計および使用されます。一つの研究室。これらの検査は、人体解剖学から採取した標本から、タンパク質、グルコースやコレステロールなどの化合物、DNA などの広範な分析対象物質を推定または区別するために利用できます。研究室や薬局が正確でエラーのない分析を行うための自動体外診断 (IVD) 手法の拡大により、この増加が加速すると予想されます。
市場の概要とダイナミクス
欧州の研究所開発のテスト市場は、89 億 8,878 万米ドルに達すると予測されています2021年の56億6,443万米ドルから2028年までに。 2021 年から 2028 年までに 6.8% の CAGR で成長すると推定されています。ヨーロッパ全土でのがんや遺伝性疾患の発生率の増加と、発売される製品の数の増加が、研究所で開発された検査市場を推進する要因となっています。しかし、規制情勢の変化が臨床開発試験市場の成長を妨げています。
LDT は研究室内で開発および使用され、他の研究室や医療施設に配布または販売されることはありません。これらのテストは、商用テストが利用できないという課題を克服するために設計されています。多くの LDT は、希少疾患のために開発された遺伝子検査です。したがって、新しい LDT の開発と導入の頻度は高くなります。2020 年 11 月、Aditx Therapeutics, Inc は、免疫モニタリングのための AditxtScore 検査室業務の CLIA 認定を取得し、これにより、新型コロナウイルス感染症 (COVID-19) を診断するための AditxtScore 検査を開始できるようになりました。 SARS-CoV-2 変異体の出現が増加していることにより、ウイルスゲノム全体にわたって変異を特定、追跡、追跡する必要性が浮き彫りになっています。 2021年1月、EurofinsはSARS-CoV-2の新しい変異株を検出および監視するためのNovaType検査を開始した。この RT-PCR アッセイは、B.1.1.7 および B.1.351 バリアントを短時間で特定できることが臨床的に検証されています。 NovaType はドイツではすでに LDT として利用可能であり、世界中の 50 以上の Eurofins 研究所で患者の新型コロナウイルス感染症を検査するために利用可能になる予定です。また、個別化医療に対する需要の高まりは、欧州の臨床検査市場で事業を展開する企業に大きな成長の機会をもたらしています。
欧州各国では、新型コロナウイルス感染症の再拡大を目の当たりにしています。パンデミックの緩和に成功した後のケース。多くの国では、2020 年の第 1 波よりも多くの症例が毎日報告されています。多くの国の政府は検査能力の拡大に取り組んでおり、それが研究所開発の検査市場をさらに推進しています。多くの市場関係者が需要の高まりに応える製品を発売しています。たとえば、2020年8月にEurofins Technologies(ルクセンブルク)は、新型コロナウイルス感染症にさらされた患者のELISAによる血清学に基づく抗体検出のための一連の検査キットを発売した。これらのテストは、新型コロナウイルス感染症に対する地域固有の要件を満たすように設計されています。 Viracor Eurofins は、研究室で開発された SARS-CoV-2 検査について食品医薬品局 (FDA) および緊急使用許可 (EUA) を取得しました。他のユーロフィン研究所は、地域の規制義務を満たし、試薬サプライチェーンの問題を世界的に軽減するために、代替の RT-PCR オプションを開発しました。しかし、緊急以外の他の検査数は、ロックダウン措置と医療機関の過剰な負担により減少しました。
<スパン>主要な市場セグメント
ヨーロッパの研究所開発の検査市場は、タイプ別に、臨床生化学、救命救急、血液学、微生物学、分子診断、免疫学に分類されています。 、およびその他のテストの種類。血液学分野は、凝固および止血、ヘモグロビン検査、血球検査などに細分化されました。分子診断セグメントは、2021 年に最大の市場シェアを保持すると予想されます。ただし、血液学セグメントは、予測期間中に最も高い CAGR を記録すると予想されます。
ヨーロッパの研究所が開発した検査市場は用途別に、学術機関、臨床研究機関、病院の研究室、専門診断センターなどに分類されます。病院検査部門は、2021 年に最大の市場シェアを保持すると予想されます。ただし、専門診断センター部門は、予測期間中に最も高い CAGR を記録すると予想されます。
リストされている主要な情報源と企業
いくつか欧州検査機関開発検査市場レポートを作成する際に参照される一次および二次情報源は、ドイツ診断産業協会 (VDGH)、Deutsche Akkreditierungsstelle GmbH (DAkkS)、およびスペイン心臓財団 (FEC) です。
< p>レポートを購入する理由 >
- 今後数年間のヨーロッパの研究所が開発したテスト市場の詳細な傾向分析に基づいて、将来の投資分野を決定します。
- 支出上位国におけるさまざまな依存症治療薬分野の需要を促進する根本的な要因を深く理解します。それぞれの企業が提供する機会を特定します。
- 需要促進要因、業界のトレンド、最新の技術開発などの観点から、市場に関する知識を強化します。 >
- ヨーロッパのジルチアゼム市場を牽引する主要チャネルを特定し、将来の機会の明確なイメージを提供します。分析に役立ち、収益拡大につながります。
- 各国が実施している進行中のプログラムに焦点を当ててリソースを集中させる < span>ヨーロッパの研究所が開発したテスト市場。
< span>ヨーロッパ研究所が開発したテスト市場のセグメンテーション
タイプ別
- < scan>臨床生化学
- 救命救急
- 血液学
- 凝固と止血、
- ヘモグロビン検査
- 血球数検査
- その他
- 免疫学
- 微生物学
- 分子診断
- その他の検査タイプ
作成者: アプリケーション
- 学術機関
- 臨床研究機関
- 病院の研究室
- 専門分野診断センター
- その他
国別
- イタリア
- フランス
- ドイツ
- スペイン
- 英国
- その他のヨーロッパ
会社概要
- Quest Diagnostics Incorporated
- F.HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- >Eurofins Scientific
- ガーダント ヘルス
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Laboratory Developed Test Market – By Type
1.3.2 Europe Laboratory Developed Test Market – By Application
1.3.3 Europe Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Europe Analysis
6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Europe Analysis
9.1 Europe: Laboratory Developed Test Market
9.1.1 Overview
9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.7 Guardant Health
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 21. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Europe Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Europe and PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
- Quest Diagnostics Incorporated
- F.HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Guardant Health
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.